Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro
S Cos1, F Fernández, E J Sánchez-Barceló
1Department of Physiology and Pharmacology, School of Medicine, University of Cantabria, Santander, Spain.
Abstract:
The aim of the present work was to study whether physiological doses of melatonin (1nM) modified DNA synthesis in MCF-7 human breast cancer cells. Exponentially growing MCF-7 cells were incubated for 24 h with thymidine (2mM) for blocking mitosis and synchronizing the cell division cycle. Synchronization was assessed by a flow cytometry study which showed that after release from excess thymidine, 82.3% of the cells were in phase G1. Lots of these synchronized cells were pulsed for 1h with [3H]deoxythymidine ([3H]dThy) or [3H]dThy + melatonin, at 0,3,6,9,12,15 or 24 h from the release of the mitotic arrest. The exposition of these synchronized MCF-7 cells to melatonin for only 1h, significantly inhibited [3H]dThy incorporation when it was at 6 or 9 h. after release from mitotic block, at a time when DNA precursor incorporation was the highest and the number of cells in S phase was maximum. We conclude that, at least in part, melatonin antiproliferative effects on MCF-7 cells could be mediated by a reduction of DNA synthesis.
Insights
Melatonin (1nM) significantly reduced DNA synthesis in synchronized human breast cancer (MCF-7) cells. This suggests melatonin
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Melatonin is a hormone with potential anticancer properties.
- MCF-7 cells are a human breast cancer cell line commonly used in research.
- Understanding melatonin's effects on DNA synthesis is crucial for cancer research.
Purpose of the Study:
- To investigate the impact of physiological melatonin doses on DNA synthesis in MCF-7 cells.
- To determine if melatonin affects DNA precursor incorporation during specific cell cycle phases.
Main Methods:
- MCF-7 cells were synchronized using thymidine block and released.
- DNA synthesis was measured by [3H]deoxythymidine incorporation.
- Cells were exposed to melatonin (1nM) for 1 hour at various time points post-release.
Main Results:
- Melatonin (1nM) significantly inhibited [3H]deoxythymidine incorporation at 6 and 9 hours after mitotic release.
- This inhibition occurred when DNA precursor incorporation and S-phase cell numbers were highest.
- A 1-hour melatonin exposure was sufficient to cause this effect.
Conclusions:
- Melatonin's antiproliferative effects on MCF-7 cells may be partly mediated by reducing DNA synthesis.
- Physiological melatonin levels can impact DNA replication in breast cancer cells.
- Further research is warranted to explore melatonin's therapeutic potential in breast cancer.
Related Concept Videos
01:23Negative Regulator Molecules
01:46Epigenetic Regulation
02:23Abnormal Proliferation
01:37Epigenetic Regulation
X-chromosome...